MARKET

ATXS

Astria Therapeutics Inc
ATXS
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-7.4952
5.80
3.044
718,127,262.04
BioCryst 2025 revenue rises 94% on ORLADEYO sales
Reuters · 02/26 12:19
BioCryst posts FY 2025 non-GAAP operating profit of USD 214.2 million (+198%)
Reuters · 02/26 12:07
Weekly Report: what happened at ATXS last week (0119-0123)?
Weekly Report · 01/26 10:21
Astria Therapeutics Secures $400 Million Term Loan in BioCryst Merger Financing
Reuters · 01/26 07:42
BioCryst Completes Acquisition of Astria Therapeutics
Reuters · 01/26 07:10
Astria Therapeutics Completes Merger and Goes Private
TipRanks · 01/23 22:37
*News On Astria Therapeutics Inc. (ATXS) Now Under BCRX
Dow Jones · 01/23 22:08
BioCryst Pharmaceuticals Amends Board Appointment Disclosure
Reuters · 01/23 21:33
More

Webull offers Astria Therapeutics Inc stock information, including NASDAQ: ATXS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ATXS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ATXS stock methods without spending real money on the virtual paper trading platform.